Implementing HIV Pre-Exposure Prophylaxis in a Family Planning Clinic: A Study of Feasibility and Acceptability (The Pilot Fish Study)

What this Trial Is About

Researchers are evaluating how patients and physicians feel about offering medications called pre-exposure prophylaxis (PrEP) to prevent HIV in a family planning clinic. The study focuses on whether patients find it acceptable to be asked about PrEP during their clinic visits, as well as understanding the challenges and supports for discussing and starting PrEP in this setting. The study aims to provide data to help design better ways to offer PrEP in family planning clinics. The study offers standardized counseling about PrEP to patients and provides an opportunity to begin PrEP as part of routine care. Physicians receive training on a standardized PrEP screening and initiation protocol and support patients interested in starting PrEP. There is no control group; this is a pilot study to assess feasibility and acceptability of integrating PrEP into family planning services. Participants will complete surveys about their experiences with PrEP screening and initiation. Patients complete a post-intervention survey and receive a gift card, while physicians complete pre- and post-study surveys and some may take part in in-depth interviews. Researchers measure how acceptable, feasible, and appropriate the intervention is for both patients and physicians during the study period, which lasts up to 12 months for physicians and up to 6 hours for patients.

Bringing Medicines for HIV Prevention to a Family Planning Clinic